The company usually posts poor financials for mid or long term investments.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 0.29 USD in weekly data.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
As estimated by analysts, this group is among those businesses with the lowest growth prospects.
Low profitability weakens the company.
One of the major weak points of the company is its financial situation.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.